Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination

Código QR

Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination

The emergence of effective vaccines for COVID-19 has been welcomed by the world with great optimism. Given their increased susceptibility to COVID-19, the question arises whether individuals with type-2 diabetes mellitus (T2DM) and other metabolic conditions can respond effectively to the mRNA-based...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hamad Ali, Abdulmohsen Alterki, Sardar Sindhu, Barrak Alahmad, Maha Hammad, Salman Al-Sabah, Mohammad Alghounaim, Mohammad H. Jamal, Ali Aldei, Mohammad J. Mairza, Maitham Husain, Sriraman Deverajan, Rasheed Ahmad, Preethi Cherian, Irina Alkhairi, Abdullah Alkandari, Jehad Abubaker, Mohamed Abu-Farha, Fahd Al-Mulla
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	COVID-19 diabetes mellitus type 2 vaccine mRNA vaccine BNT162b2 T2D Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/1e20e1ab130b4508b7d668fccca55432
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Previous COVID-19 Infection and Antibody Levels After Vaccination
por: Hamad Ali, et al.
Publicado: (2021)

Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study
por: Mohammad Shehab, et al.
Publicado: (2021)

Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns
por: Matteo Nioi, et al.
Publicado: (2021)

Safety and efficacy of RNA vaccines: State of the art
por: A. V. Blagov, et al.
Publicado: (2021)

B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies
por: Federica Pulvirenti, et al.
Publicado: (2021)

Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study
por: Rana Shibli, et al.
Publicado: (2021)

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
por: Peter Bergman, MD, et al.
Publicado: (2021)

Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose
por: Ilaria Vicenti, et al.
Publicado: (2021)

B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies
por: Hao Zhou, et al.
Publicado: (2021)

Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe
por: Arkadiusz Dziedzic, et al.
Publicado: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
por: Shaikh Terkis Islam Pavel, et al.
Publicado: (2021)

Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
por: Kadhim Hayawi, et al.
Publicado: (2021)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
por: Piotr Rzymski, et al.
Publicado: (2021)

Prevalence and Factors Associated with Parents’ Non-Intention to Vaccinate Their Children and Adolescents against COVID-19 in Latin America and the Caribbean
por: Diego Urrunaga-Pastor, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy in the United States: A Systematic Review
por: Farah Yasmin, et al.
Publicado: (2021)

COVID-19: an updated review
por: F. A. Isihak, et al.
Publicado: (2020)

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
por: Bruna Aparecida Souza Machado, et al.
Publicado: (2021)

Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
por: Soheil Ghasemi, et al.
Publicado: (2021)

COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
por: Piotr Rzymski, et al.
Publicado: (2021)

Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
por: Isabel Iguacel, et al.
Publicado: (2021)

Regional Differences in COVID-19 Vaccine Hesitancy in December 2020: A Natural Experiment in the French Working-Age Population
por: Fanny Velardo, et al.
Publicado: (2021)

COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand
por: May Sirikalyanpaiboon, et al.
Publicado: (2021)

Nursing and its Essential Role in the Vaccination against COVID-19: New Challenge in a Pandemic Scenario
por: R. Mauricio Barría P
Publicado: (2021)

Investigating Adherence to COVID-19 Vaccination and Serum Antibody Concentration among Hospital Workers—The Experience of an Italian Private Hospital
por: Guglielmo Forgeschi, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy and Emerging Variants: Evidence from Six Countries
por: Sherry Mangla, et al.
Publicado: (2021)

An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
por: Mohammad Enamul Hoque Kayesh, et al.
Publicado: (2021)

The Barriers, Challenges, and Strategies of COVID-19 (SARS-CoV-2) Vaccine Acceptance: A Concurrent Mixed-Method Study in Tehran City, Iran
por: Hamid Reza Khankeh, et al.
Publicado: (2021)

The relationship between macro-socioeconomics determinants and COVID-19 vaccine distribution
por: Ali Roghani
Publicado: (2021)

Sudden sensorineural hearing loss after COVID-19 vaccination
por: Junhui Jeong, et al.
Publicado: (2021)

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
por: Robert Flisiak, et al.
Publicado: (2021)

COVID-19 and Historic Influenza Vaccinations in the United States: A Comparative Analysis
por: Pranav Mirpuri, et al.
Publicado: (2021)

Predictors of COVID-19 Vaccination among Veterans Experiencing Homelessness
por: Michelle D. Balut, et al.
Publicado: (2021)

Immune thrombocytopenia relapse post covid-19 vaccine in young male patient
por: Hana Qasim, et al.
Publicado: (2021)

Explaining COVID-19 Vaccine Rejection Using Social Cognitive Theory in Qassim, Saudi Arabia
por: Aseel Ali AlSaeed, et al.
Publicado: (2021)

CLINICAL STUDIES OF THE VACCINE PREPARATION FOR PREVENTION OF FLEXNER DYSENTERY ON THE BASIS OF MODIFIED SHIGELLA FLEXNERI LIPOPOLYSACCHARIDE (BASED ON THE RESULTS OF THE I PHASE OF CLINICAL TRIALS)
por: V. A. Lyodov, et al.
Publicado: (2014)

Vaccine
Publicado: (1983)

Attitudes and Intentions toward COVID-19 Vaccination among Health Professions Students and Faculty in Qatar
por: Amine Zaidi, et al.
Publicado: (2021)

Pregnancy as a Risk Factor of Severe COVID-19
por: Aleksander Celewicz, et al.
Publicado: (2021)

Knowledge, Attitudes and Perception toward COVID-19 Vaccines among Adults in Jazan Province, Saudi Arabia
por: Edrous Alamer, et al.
Publicado: (2021)

Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
por: I. Losev, et al.
Publicado: (2019)